By Bhanvi Satija LONDON (Reuters) -German biotech firm Tubulis said on Wednesday it had raised 308 million euros ($358 ...
When doctors told the father of two his cancer was seen just three times a year in Oregon, he found a lifeline 2,000 miles ...
Uterine cancer symptoms include irregular bleeding and pelvic pain, but early diagnosis through medical evaluation can lead ...
OVATION 3 is IMUNON’s pivotal Phase 3 study of IMMN-001, an IL-12 gene-mediated immunotherapy, in women with advanced stage epithelial ovarian cancer. The study is supported with unprecedented overall ...
DeepSeek, a blood test that can detect HPV-linked head and neck cancers nearly a decade before diagnosis. By finding viral ...
Pooled analysis supports the rationale for the ongoing MAIA-ovarian trial evaluating COM701 as maintenance therapy in the earlier setting of platinum sensitive ovarian cancer HOLON, Israel, Oct. 13, ...
Preventing relapse of advanced ovarian cancer with PARP inhibitors is now an established strategy. As data from pivotal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback